Search hospitals > Washington > Seattle
Fred Hutchinson Cancer Research Center
Claim this profileSeattle, Washington 98109
Global Leader in Leukemia
Global Leader in Cancer
Conducts research for Lymphoma
Conducts research for Myeloid Leukemia
Conducts research for Acute Myeloid Leukemia
818 reported clinical trials
106 medical researchers
Summary
Fred Hutchinson Cancer Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Leukemia, Cancer, Lymphoma, Myeloid Leukemia, Acute Myeloid Leukemia and other specialties. Fred Hutchinson Cancer Research Center is involved with conducting 818 clinical trials across 931 conditions. There are 106 research doctors associated with this hospital, such as Michael Schweizer, Michael J Wagner, MD, Christina S. Baik, and Stephen Smith.Area of expertise
1Leukemia
Global LeaderHLA positive
HLA negative
HLA-A positive
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Michael SchweizerFred Hutch/University of Washington Cancer Consortium4 years of reported clinical research
Expert in Prostate Cancer
Studies Prostate Adenocarcinoma
13 reported clinical trials
26 drugs studied
Michael J Wagner, MDFred Hutchinson Cancer Research Center4 years of reported clinical research
Studies Liposarcoma
Studies Sarcoma
13 reported clinical trials
19 drugs studied
Christina S. BaikFred Hutchinson Cancer Research Center5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
18 drugs studied
Stephen SmithFred Hutch/University of Washington Cancer Consortium1 year of reported clinical research
Studies Lymphoma
Studies Follicular Lymphoma
9 reported clinical trials
27 drugs studied
Clinical Trials running at Fred Hutchinson Cancer Research Center
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Follicular Lymphoma
Cancer
Ovarian Cancer
Lymphoma
Leukemia
Letrozole
for Breast Cancer
This stage IV trial examines how a mutation in HSD3B1 (1245C) gene affects treatment of stage I-III breast cancer. This trial may help researchers determine if mutations in HSD3B1 decreases the efficacy of aromatase inhibitor therapy such as letrozole. Letrozole may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Recruiting3 awards Phase 410 criteria
Cancer Vaccine
for Triple Negative Breast Cancer
This trial studies the effect of a special vaccine called STEMVAC, given with sargramostim, in patients with a hard-to-treat type of breast cancer. The vaccine helps the immune system recognize and attack cancer cells. The goal is to see how well the immune system responds to this treatment. STEMVAC is a type of cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells.
Recruiting2 awards Phase 218 criteria
Gedatolisib + Fulvestrant +/- Palbociclib
for Advanced Breast Cancer
This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fred Hutchinson Cancer Research Center?
Fred Hutchinson Cancer Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Leukemia, Cancer, Lymphoma, Myeloid Leukemia, Acute Myeloid Leukemia and other specialties. Fred Hutchinson Cancer Research Center is involved with conducting 818 clinical trials across 931 conditions. There are 106 research doctors associated with this hospital, such as Michael Schweizer, Michael J Wagner, MD, Christina S. Baik, and Stephen Smith.
Where is Fred Hutchinson Cancer Research Center located?
**Fred Hutchinson Cancer Research Center**
- **Address:** 1100 Fairview Ave N, Seattle, WA 98109
- **Directions:** From downtown Seattle, take the South Lake Union Streetcar to the Westlake Ave N & Mercer St stop. From there, it's a 10-minute walk northwest on Fairview Ave N.
Who should I call to ask about financial aid or insurance network?
**Fred Hutchinson Cancer Research Center Financial Assistance and Insurance Departments**
- **Financial Counseling Department**
- **Address:** 825 Eastlake Ave. East, Seattle, Washington, 98109
- **Phone:** (206) 606-6226 or toll-free at 1 (800) 304-1763
- **Email:** fincounsel@fredhutch.org
- **Website:** [Financial Assistance Information](https://www.fredhutch.org/en/patient-care/patient-services/insurance-and-billing/financial-assistance.html)
- **Patient Financial Services Department**
- **Phone:** (206) 606-6226 or toll-free at 1 (800) 304-1763
- **Email:** fincounsel@fredhutch.org
- **Website:** [Financial Assistance Information](https://www.fredhutch.org/en/patient-care/patient-services/insurance-and-billing/financial-assistance.html)
These departments offer support with financial assistance applications, insurance queries, and billing issues.
What insurance does Fred Hutchinson Cancer Research Center accept?
The Fred Hutchinson Cancer Research Center accepts a wide range of insurance plans, including but not limited to Aetna, Allways Health Partners, Ambetter, BCBS, CIGNA, First Health, Harvard Pilgrim, Humana, MEDICA, MVP Health Plan, Medicare Advantage, Molina, Multiplan, PacificSource, Premera, Regence, Tufts, UHC, and WPS Group. Additionally, employees have the option to choose between Premera Blue Cross or Kaiser Permanente Health Plan of Washington. Premera Blue Cross plans utilize a healthcare provider network, whereas Kaiser Permanente's HMO Core Plan offers integrated services with benefits coordinated through network providers, emphasizing small copays for in-network services and emergency coverage only outside the network.
What awards or recognition has Fred Hutchinson Cancer Research Center received?
Fred Hutchinson Cancer Research Center in Seattle, Washington, is renowned for its significant contributions to cancer research and care. It has merged with Seattle Cancer Care Alliance under UW Medicine, creating a unified, independent nonprofit organization dedicated to adult cancer research and care. The center excels in business development, boasting successful ventures like Juno Therapeutics and Adaptive Biotechnologies, and actively works to improve community health through its Community Grants Program.